BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 26897077)

  • 1. The role of cystatin C as a biomarker for prognosis in pulmonary arterial hypertension due to congenital heart disease.
    Blok IM; van Riel AC; Schuuring MJ; de Bruin-Bon RH; van Dijk AP; Hoendermis ES; Zwinderman AH; Mulder BJ; Bouma BJ
    Int J Cardiol; 2016 Apr; 209():242-7. PubMed ID: 26897077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New predictors of mortality in adults with congenital heart disease and pulmonary hypertension: Midterm outcome of a prospective study.
    Schuuring MJ; van Riel AC; Vis JC; Duffels MG; van Dijk AP; de Bruin-Bon RH; Zwinderman AH; Mulder BJ; Bouma BJ
    Int J Cardiol; 2015 Feb; 181():270-6. PubMed ID: 25535690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality in pulmonary arterial hypertension due to congenital heart disease: Serial changes improve prognostication.
    Schuijt MTU; Blok IM; Zwinderman AH; van Riel ACMJ; Schuuring MJ; de Winter RJ; Duijnhouwer AL; van Dijk APJ; Mulder BJM; Bouma BJ
    Int J Cardiol; 2017 Sep; 243():449-453. PubMed ID: 28606655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein in adults with pulmonary arterial hypertension associated with congenital heart disease and its prognostic value.
    Scognamiglio G; Kempny A; Price LC; Alonso-Gonzalez R; Marino P; Swan L; D' Alto M; Hooper J; Gatzoulis MA; Dimopoulos K; Wort SJ
    Heart; 2014 Sep; 100(17):1335-41. PubMed ID: 24790070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
    Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
    [No Abstract]   [Full Text] [Related]  

  • 6. High-sensitivity troponin T is associated with poor outcome in adults with pulmonary arterial hypertension due to congenital heart disease.
    Schuuring MJ; van Riel AC; Vis JC; Duffels MG; van Straalen JP; Boekholdt SM; Tijssen JG; Mulder BJ; Bouma BJ
    Congenit Heart Dis; 2013; 8(6):520-6. PubMed ID: 23241414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Creatinine versus cystatin C to estimate glomerular filtration rate in adults with congenital heart disease: Results of the Boston Adult Congenital Heart Disease Biobank.
    Opotowsky AR; Carazo M; Singh MN; Dimopoulos K; Cardona-Estrada DA; Elantably A; Waikar SS; Mc Causland FR; Veldtman G; Grewal J; Gray C; Loukas BN; Rajpal S
    Am Heart J; 2019 Aug; 214():142-155. PubMed ID: 31203159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood biomarkers and their potential role in pulmonary arterial hypertension associated with congenital heart disease. a systematic review.
    Giannakoulas G; Mouratoglou SA; Gatzoulis MA; Karvounis H
    Int J Cardiol; 2014 Jul; 174(3):618-23. PubMed ID: 24814894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron deficiency in pulmonary arterial hypertension associated with congenital heart disease.
    Yu X; Zhang Y; Luo Q; Liu Z; Zhao Z; Zhao Q; Gao L; Jin Q; Yan L
    Scand Cardiovasc J; 2018 Dec; 52(6):378-382. PubMed ID: 30632395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystatin C: a potential biomarker for pulmonary arterial hypertension.
    Fenster BE; Lasalvia L; Schroeder JD; Smyser J; Silveira LJ; Buckner JK; Brown KK
    Respirology; 2014 May; 19(4):583-9. PubMed ID: 24628703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of Pulmonary Artery Compliance in Patients with Pulmonary Arterial Hypertension Associated with Adult Congenital Heart Disease.
    Cheng XL; Liu ZH; Gu Q; Ni XH; Luo Q; Zhao ZH; He JG; Xiong CM
    Int Heart J; 2017 Oct; 58(5):731-738. PubMed ID: 28966315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
    Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ivabradine therapy on heart failure biomarkers.
    Ordu S; Yildiz BS; Alihanoglu YI; Ozsoy A; Tosun M; Evrengul H; Kaftan HA; Ozhan H
    Cardiol J; 2015; 22(5):501-9. PubMed ID: 25733317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers in stable coronary heart disease, their modulation and cardiovascular risk: The LIPID biomarker study.
    Tonkin AM; Blankenberg S; Kirby A; Zeller T; Colquhoun DM; Funke-Kaiser A; Hague W; Hunt D; Keech AC; Nestel P; Stewart R; Sullivan DR; Thompson PL; West M; White HD; Simes J;
    Int J Cardiol; 2015 Dec; 201():499-507. PubMed ID: 26318511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of renal function in precapillary pulmonary hypertension.
    Kaiser R; Seiler S; Held M; Bals R; Wilkens H
    J Intern Med; 2014 Feb; 275(2):116-26. PubMed ID: 24011362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
    Skoglund PH; Arpegård J; Ostergren J; Svensson P
    Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Significance of Biomarkers in Pulmonary Arterial Hypertension.
    Al-Naamani N; Palevsky HI; Lederer DJ; Horn EM; Mathai SC; Roberts KE; Tracy RP; Hassoun PM; Girgis RE; Shimbo D; Post WS; Kawut SM;
    Ann Am Thorac Soc; 2016 Jan; 13(1):25-30. PubMed ID: 26501464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil gelatinase-associated lipocalin, cystatin C and eGFR indicate acute kidney injury and predict prognosis of patients with acute pulmonary embolism.
    Kostrubiec M; Łabyk A; Pedowska-Włoszek J; Dzikowska-Diduch O; Wojciechowski A; Garlińska M; Ciurzyński M; Pruszczyk P
    Heart; 2012 Aug; 98(16):1221-8. PubMed ID: 22705926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of N-Terminal Pro-Brain Natriuretic Peptide to Predict Mortality in Adults With Congenital Heart Disease.
    Popelová JR; Kotaška K; Tomková M; Tomek J
    Am J Cardiol; 2015 Nov; 116(9):1425-30. PubMed ID: 26404943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetric Dimethyl-L-Arginine is a Biomarker for Disease Stage and Follow-Up of Pulmonary Hypertension Associated with Congenital Heart Disease.
    Fang ZF; Huang YY; Tang L; Hu XQ; Shen XQ; Tang JJ; Zhou SH
    Pediatr Cardiol; 2015 Jun; 36(5):1062-9. PubMed ID: 25737007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.